Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female and aged between 18 and 99 years
- People who have been diagnosed with epithelial ovarian cancer confirmed through tissue or cell testing
- People whose case was reviewed by the Multidisciplinary Tumor Board at the AUSL-IRCCS hospital in Reggio Emilia, Italy
- People who received treatment between January 1, 2018, and December 31, 2023
- People whose medical records and health outcome information are available
- People who have signed an informed consent form where possible, in line with privacy laws in Italy and the EU
Who may not be able to join:
- People who do not have a confirmed diagnosis of epithelial ovarian cancer through tissue or cell testing
- People whose medical records are incomplete or have key clinical information missing
- People who are unable to give informed consent and cannot be contacted by the trial team
- People who are considered unable to understand and agree to consent due to reasons such as severe cognitive impairment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vincenzo Dario Mandato, MD, Azienda USL - IRCCS di Reggio Emilia
Phone: +39 0522 295467
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-Free Survival (PFS); Overall Survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.